Oncology & Cancer

Risk factors identified for late recurrence of liver cancer

(HealthDay)—Late recurrence after hepatocellular carcinoma (HCC) resection is associated with sex, cirrhosis, and several aggressive tumor characteristics of the initial HCC, according to a study recently published in JAMA ...

Oncology & Cancer

Preclinical study finds antitumor effects of bispecific antibody

Chugai Pharmaceutical announced today that the preclinical study findings on its original bispecific antibody ERY974, a molecule that binds Glypican-3 and CD3 simultaneously, and that is currently under development as a Phase ...

Diseases, Conditions, Syndromes

HOMA2-IR tied to hepatocellular carcinoma risk in hepatitis B

(HealthDay)—Insulin resistance assessed by homeostasis model assessment index (HOMA2-IR) correlates with the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection, according to ...

Oncology & Cancer

Pathogenesis to management of hepatocellular carcinoma

A new review was published in Genes & Cancer on December 13, 2022, entitled, "Pathogenesis to management of hepatocellular carcinoma." In this review, researchers from multiple universities and medical centers across the ...

page 9 from 19